enocitabine has been researched along with Preleukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Fujii, H; Horiike, S; Inazawa, J; Misawa, S; Nakagawa, H; Sonoda, Y; Tanaka, S; Taniwaki, M; Tsuda, S | 1 |
| Nakada, H; Takahashi, I | 1 |
2 other study(ies) available for enocitabine and Preleukemia
| Article | Year |
|---|---|
[Relation of karyotypic findings to chemotherapy response in patients with preleukemia].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Aberrations; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Cytarabine; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia | 1989 |
[Chemotherapeutic effects in hypoplastic leukemia].
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Evaluation; Humans; Immunoglobulin G; Immunotoxins; Infusions, Intravenous; Leukemia, Myeloid, Acute; Melphalan; Middle Aged; Preleukemia | 1988 |